Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 05 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Difelikefalin (Primary)
Indications Postoperative pain
Focus Registrational; Therapeutic Use
Sponsors Cara Therapeutics

Most Recent Events

27 Jun 2018 Primary endpoint (A comparison of the change in Pain Intensity over time using the Numeric Rating Scale (AUC 0-24)) has been met, according to the Cara Therapeutics media release.
27 Jun 2018 According to a Cara Therapeutics media release, the full results of this trial will be presented at a future scientific or medical conference.
27 Jun 2018 Results presented in the Cara Therapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com